臺灣博碩士論文加值系統

急性胰臟炎會導致全身性發炎反應，在臨床上也會引起嚴重的併發症，一般認為免疫風暴在急性胰臟炎的病生理學上扮演重要角色。由多形性白血球所媒介之多重器官衰竭需要分解細胞基質，因此基質金屬蛋白酵素參與多形性白血球的組織侵犯是合理的推論。
在本研究發現，多劑量的腹腔注射cerulein藥物可以誘發小鼠產生急性胰臟炎。更進一步，本研究建立一種新的動物模型，模擬急性胰臟炎併發腹腔感染。另一方面，探討基質金屬蛋白酵素在各種有無合併感染的急性胰臟炎動物模型上的表現，結果顯示基質金屬蛋白酵素在急性胰臟炎合併感染時有高度的表現。在本研究同時顯示，脂多醣及腫瘤壞死因子與全血反應，可促進金屬蛋白酵素的釋放。依據以上的發現，基質金屬蛋白酵素可以做為急性胰臟炎合併感染時的早期指標。

Acute pancreatitis causes systemic inflammatory response syndrome and potentially results in severe complications clinically. It is generally believed that cytokine storm plays a major role in the pathogenesis of acute pancreatitis. PMN-mediated multiple organ injury requires extracellular matrix degradation. MMPs are reasonable considered to involve the process of tissue invasion by PMNs.
In this study, we demonstrated that repeated dose of intra-peritoneal cerulein injection induced acute pancreatitis in mice. Furthermore, we established a new animal model that mimic acute pancreatitis complicated with intra-abdominal infection. In addition, we investigate the expression of MMP-9 in different animal models of acute pancreatitis with or without intra-abdominal infection. The results showed that MMP-9 was significantly expressed in acute pancreatitis combined with intra-abdominal infection. The data presented in this study indicate that MMP-9 are released in whole blood in response to LPS and TNF-???| According to the above findings, MMP-9 can be a useful marker in detecting early infection during acute pancreatitis.

目錄 (1)
縮寫表(2)
中文摘要(3)
英文摘要(4)
壹、緒論(5)
文獻回顧(5)
研究目的(15)
實驗設計(16)
貳、究材料與方法(18)
實驗材料(18)
實驗方法(21)
參、結果(29)
肆、討論(38)
伍、結論與展望(43)
陸、附圖(44)
柒、圖表(46)
捌、參考文獻(65)

Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1and tumor necrosis factor-?? in rheumatoid arthritis. Arthritis Rheum 1995;38:151-160.

Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 2002;1:343-351.

Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L. Pathophysiology of acute pancreatitis. Pancreatology 2005;5:132-144.

Birkedal-Hansen H, Moore WG I, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4 (2):197-250.

Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase -9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol 2006;79:214-222.

Chan YC, Leung PS. Acute pancreatitis：animal models and recent advances in basic research. Pancreas 2007;34:1-14.

Chao KC, Chao KF, Chuang CC, Liu SH. Blockade of interleukin 6 accelerates acinar cell apoptosis and attenuates experimental acute pancreatitis in vivo. Br J Surg 2006;93: 332-338.

Chen P, Yuan Y, Wang S, Zhan L, Xu J. Captopril, an angiotensin-converting enzyme inhibitor, attenuates the severity of acute pancreatitis in rats by reducing expression of matrix metalloproteinase 9. Tohoku J Exp Med 2006;209:99-107.

Dominguez-Munoz JE, Viedma JA and Perez-Mateo M. Inflammatory response in the initial phase of acute pancreatitis：relationship to the onset and severity of the disease. Rev Esp Enferm Dig 1995;87:225-246.

Elkington PTG, O’Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005; 142:12-20.


Frossard J-L, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001;164:162-170.

Granell S, Pereda J, Gomez-Cambronero L, Cassinello N, Sabater L, Closa D, Sastre J. Circulating TNF-?? and its soluble receptors during experimental acute pancreatitis. Cytokine 2004;25:187-191.

Heinrich S, Schafer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243(2):154-168.

Hirota M, Nozawa F, Okabe A, Shibata M, Beppu T, Shimada S, Egami H, Yamaguchi Y, Ikei S, Okajima K, Okamoto K, Ogawa M. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000;21:141-146.

Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue lll LW, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock 2005;24. suppl.:52-57.

Imrie CW. Acute pancreatitis：overview. Eur J Gastroenterol Hepatol 1997;9:103-105.

Keck T, IV JHB, Castillo CF, Antoniu BA, Warshaw AL. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002;122:188-201.

Keck T, Jargon D, Klunsch A, Thomusch O, Richter S, Friebe V, Adam U, Hopt UT. MMP-9 in serum correlates with the development of pulmonary complications in experimental acute pancreatitis. Pancreatology 2006;6:316-322.

Kerr LD, Miller DB, Matrisian LM. TGF-β inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 1991;61:267-278.

Kolaczkowska E, Arnold B, Opdenakker G. Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils. Immunobiology 2008;213:109-124.

Lacraz S, Nicod L, Galve-de RB, Baumberger C, Dayer JM, Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992;90:382-388.

Lankisch PG, Lerch MM. The role of antibiotic prophylaxis in the treatment of acute pancreatitis. J Clin Gastroenterol 2006;40:149-155.

Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9: 401-410.

Malleo G, Mazzon E, Genovese T, Paola RD, Muia C, Centorrino T, Siriwardena A K, Cuzzocrea S. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-?? genetic deletion. Shock 2007;27:542-551.

Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-???nin acute pancreatitis: from biological basis to clinical evidence. Shock 2007;28:130-140.

Marshall JC. Lipopolysaccharide：an endotoxin or an exogenous hormone ? Clin Infect Dis 2005;41:S470-480.

Mofleh IAA. Severe acute pancreatitis: Pathogenetic aspects and prognostic factors. World J Gastroenterol 2008;14(5):675-684.

Muhs BE, Patel S, Yee H, Marcus S, Shamamian P. Increased matrix metalloproteinase expression and activation follwing experimental acute pancreatitis. J Surg Res 2001;101:21-28.

Muhs BE, Patel S, Yee H, Marcus S, Shamamian P. Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis. J Surg Res 2003;109:110-117.

Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573.

Nakae H, Endo S, Inoue Y, Fujino Y, Wakabayashi G, Inada K, Sato S. Matrix metalloproteinase-1 and cytokines in patients with acute pancreatitis. Pancreas 2003;26:134-138.

Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007;117: 50-59.

Opdenakker G, Van den Steen P.E., Dubois B, Nelissen I, Coillie EV, Masure S, Proost P, Damme JV. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001;69:851-859.

Pandol SJ, Saluja AK, Imrie CW, Banks PA. Acute pancreatitis：bench to the bedside. Gastroenterology 2007;133: 1056.e1-e25.

Pugin J, Widmer MC, Kossodo S, Liang CM, Preas II HL, Suffredini AF. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 1999;20:458-464.

Ro Y, Hamada C, Io H, Hayashi K, Hirahara I, Tomino Y. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit. J Clin Lab Anal 2004;18:224-230.

Saluja AK, Bhagat L, Lee HS, Bhatia M, Frossard JL, Steer ML. Secretagogue-induced digestive enzyme activation and cell injury in rat pancreatic acini. Am J Physiol 1999;276:835-842.

Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer ML. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci USA 1989;86:8968-8971.

Sandrine SP, Marlene D, Nicole V, Daniel F. The peripheral cholecystokinin receptors. Eur J Biochem 1993;215:513-529.

Schwartz JD, Shamamian P, Monea S, Zanetta L, Eng K, Pachter HL, Mignatti P, Galloway AC. Tumor necrosis induces the release of polymorphonuclear leukocyte pro-matrix metalloproteinase 9 which is activated by plasmin but not by elastase. Am Coll Surg Surg Forum 1997;48.

Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. Immune modulation of metalloproteinase production in human macrophages：selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-??. J Clin Invest 1990; 86: 1204-1210.

Shapiro SD, Senior R M. Matrix Metalloproteinases : Matrix degradation and more. Am. J. Respir. Cell Mol. Biol. 1999; 20:1100-1102.

Stetler-Stevenson WG. Progelatinase-A activation during tumor cell invasion. Invasion Metast 1994;14:259.

Tenner S. Initial Management of Acute Pancreatitis: Critical issues during the first 72 hours. Am J Gastroenterol 2004;99:2489-2494.

Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases：structure, function and biochemistry. Circ Res 2003;92:827-839.

Yu JH, Seo JY, Kim KH, Kim H. Differentially expressed proteins in cerulean-stimulated pancreatic acinar cells: implication for acute pancreatitis. Int J Biochem Cell B 2008;40:503-516.